Ivan Ching‐Ho Ko

Chinese University of Hong Kong

Papers

2

Total Citations

14

H-Index

2

About

Dr. Ivan Ching‐Ho Ko is a leading urologic oncologist and robotic surgeon whose research centers on optimizing surgical outcomes for bladder cancer patients, particularly through robot-assisted radical cystectomy (RARC) and urinary diversion techniques. His most impactful work, published in 2024, presents multicenter results from the Asian RARC Consortium, comparing long-term outcomes of orthotopic neobladder versus ileal conduit urinary diversion. This study, which has already garnered 12 citations, provides critical evidence on the optimal method for urinary reconstruction following RARC, addressing a longstanding clinical debate. Dr. Ko’s contributions are instrumental in advancing minimally invasive surgical approaches for muscle-invasive bladder cancer, offering patients improved functional and oncologic results. His collaborative efforts within the Asian RARC Consortium highlight his role in fostering international research networks. With a focus on long-term patient outcomes and surgical innovation, Dr. Ko’s work continues to shape best practices in urologic oncology, making him a key figure in the field.

Research Focus

Key Achievements

2
H-Index
2
Papers
14
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Long-Term Outcomes of Orthotopic Neobladder Versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium
12 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago